Click Therapeutics
PrivateLast Round
Series D
Apr 9, 2026
Est. Valuation
$312.53M
Total Funding Raised
$283.23M
Company Overview
Click Therapeutics is a digital health company that offers a prescription platform for software-based medical treatments aimed at providing safe and effective digital therapies for patients with brain disorders and neuro-psychiatric conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Medical AI, Clinical Trials, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Click Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Click Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Apr 9, 2026 | ||||
| Series C | Mar 19, 2025 | ||||
| Growth Equity | Apr 3, 2024 | ||||
| Debt | Nov 6, 2023 | ||||
| Debt | Apr 15, 2022 | ||||
Series B | Oct 22, 2021 |
Click Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Growth Equity, Series D |
| Accelmed Partners II | Series B |
| HIG BioHealth Partners | Series B |
| Health Catalyst Capital Management | Series B |
| Dassault Systèmes | Series C |
| Supernode Ventures | Seed, Series A |
| Sanofi Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
25 employees laid off, representing over 25% of the team.
- Apr 9, 2026
$50M Series D round completed.
Click Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Click Therapeutics's valuation, stock price, and market status.